Silicon-rich mineral water as a non-invasive test of the 'aluminum hypothesis' in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 33, Issue 2, 2013, Pages 423-430

  Davenward, Samantha ^a   Bentham, Peter ^b   Wright, Jan ^b   Crome, Peter ^c   Job, Deborah ^c   Polwart, Anthony ^a   Exley, Christopher ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c Staffordshire   (United Kingdom)

Author keywords

aluminum; Alzheimer's disease; body burden; cognitive function; copper; iron; mineral water; silicic acid; silicon; urinary excretion

Indexed keywords

ALUMINUM; COPPER; IRON; MINERAL WATER; SILICON; SILICON RICH MINERAL WATER; UNCLASSIFIED DRUG;

ADULT; AGED; ALUMINUM HYPOTHESIS; ALZHEIMER DISEASE; ARTICLE; BODY BURDEN; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRINKING; EXPERIMENTAL TEST; FEMALE; HUMAN; MALE; NEUROLOGIC EXAMINATION; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION;

EID: 84872455725     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121231     Document Type: Article

References (21)

1. Exley C, House E (2011) Aluminium in the human brain. Monatshefte Chem Chem Monthly 142, 3357-3363.
2. House E, Esiri M, Forster G, Ince PG, Exley C (2012) Aluminium, iron and copper in human brain tissues donated to the medical research council's cognitive function and ageing study. Metallomics 4, 56-65.
3. Bondy SC (2010) The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 31, 575-581.
4. Tomljenovic L (2011) Aluminum and Alzheimer's disease: After a century of controversy, is there a plausible link? J Alzheimers Dis 23, 567-598.
5. McLachlan DRC, Dalton AJ, Kruck TPA, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308.
6. Percy ME, Kruck TPA, Pogue AI, Lukiw WJ (2011) Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. J Inorg Biochem 105, 1505-1512.
7. Exley C (2003) A biogeochemical cycle for aluminium? J Inorg Biochem 97, 1-7. (Pubitemid 37152405)
8. Exley C (2012) Elucidating aluminium's exposome. Curr Inorg Chem 2, 3-7.
9. Exley C (2009) Aluminium and medicine. In: Molecular and Supramolecular Bioinorganic Chemistry. Applications in Medical Sciences, Merce ALR, Felcman J, Recio MAL, Eds. Nova Biomedical Books, New York, pp. 45-68.
10. Crisponi G, Nurchi VM (2011) Thermodynamic remarks on chelating ligands for aluminium-related diseases. J Inorg Biochem 105, 1518-1522.
11. Exley C (2012) Reflections upon and recent insight into the mechanism of formation of hydroxyaluminosilicates and the therapeutic potential of silicic acid. Coord Chem Rev 256, 82-88.
12. Birchall JD, Exley C, Chappell JS, Phillips MJ (1989) Acute toxicity of aluminium to fish eliminated in silicon-rich acid waters. Nature 338, 146-148.
13. Edwardson JA, Moore PB, Ferrier IN, Lilley JS, Newton GWA, Barker J, Templar J, Day JP (1993) Effect of silicon on gastrointestinal absorption of aluminium. Lancet 342, 211-212. (Pubitemid 23214639)
14. Popplewell JF, King SJ, Day JP, Ackrill P, Fifield LK, Cresswell RG, Di Tada ML, Liu K (1998) Kinetics of uptake and elimination of silicic acid by a human subject: A novel application of 32Si and accelerator mass spectrometry. J Inorg Biochem 69, 177-180. (Pubitemid 28270146)
15. Exley C, Korchazhkina O, Job D, Strekopytov S, Polwart A, Crome P (2006) Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease. J Alzheimers Dis 10, 17-24. (Pubitemid 44401360)
16. Exley C, Swarbrick L, Gherardi R, Authier J-F (2009) A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 72, 135-139.
17. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV) American Psychiatric Association, Washington D.C.
18. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1364.
19. Schrag A, Schott JM (2012) What is the clinically-relevant change on the ADAS-Cog? J Neurol Neurosurg Psychiatry 83, 171-173.
20. Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia - a quantitative integration of the literature. Acta Psychiatr Scand 76, 465-479. (Pubitemid 17164786)
21. Davenward S (2012) Silicic acid-rich mineral water as a non-invasive method of reducing aluminium body burden in healthy individuals, Alzheimer's and Parkinson's disease, PhD Thesis, Keele University.